Isolde MacDonogh
Reporter at Bloomberg News
TV producer and journalist at Bloomberg. Views my own, RTs are not endorsements.
Articles
-
1 week ago |
bloomberglinea.com | Isolde MacDonogh |Tim Loh |Alex Kraus
Bloomberg — Durante años, Bayer AG ha sido una de las acciones germanas con peores resultados. En la actualidad, se está convirtiendo en una de las que más han ganado. El conglomerado farmacéutico y químico subió aproximadamente un 40% este año, situándose en la sexta posición del índice DAX en el 2025. Ha ascendido tan vertiginosamente que su precio está a un paso de rebasar el objetivo medio de los analistas para los próximos 12 meses.
-
1 week ago |
bloomberg.com | Isolde MacDonogh |Tim Loh
Nach Jahren der Börsentalfahrt hat sich die Aktie von Bayer in diesem Jahr zu einem der besten Werte im Dax entwickelt. Im laufenden Jahr hat sie rund 40% an Wert gewonnen und kommt auf der Gewinnerliste im Frankfurter Marktbarometer auf Rang sechs. Der Kursanstieg verlief so rasch, dass die Aktie kurz davorsteht, das durchschnittliche Zwölf-Monats-Kursziel der Analysten zu übertreffen.
-
1 week ago |
fortune.com | Isolde MacDonogh |Tim Loh
The pharma and chemical conglomerate soared some 40% in 2025, ranking among the top stocks in the DAX. It has risen so rapidly that the price is on the cusp of surpassing the average 12-month analyst target. Traders are betting on a possible breakthrough in Bayer’s long-running legal battle over Roundup weedkiller and that its experimental Asundexian drug might be a blockbuster treatment for preventing strokes.
-
1 week ago |
bloomberg.com | Isolde MacDonogh |Tim Loh
Bill Anderson(Bloomberg) -- For years, Bayer AG was one of Germany’s worst-performing stocks. Now, it’s turning out to be among the biggest gainers. The pharma and chemical conglomerate soared some 40% in 2025, ranking sixth in the DAX index this year. It has risen so rapidly that the price is on the cusp of surpassing the average 12-month analyst target.
-
2 weeks ago |
news.bloombergtax.com | Christoph Rauwald |Isolde MacDonogh
XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 130
- Tweets
- 35
- DMs Open
- No
Pre-close calls with analysts have been a tradition in markets for years. Some investors say the practice needs to change. https://t.co/TSwZFyHi1y via @business
RT @daniburgz: Sport investing was also a hot topic this year. But the area of most interest: media rights. As Chairman of Europe at BC Par…
RT @BloombergUK: Give us 15 minutes, and we'll get you up to speed on the business world and beyond 🎧 Get the Bloomberg Daybreak Europe po…